Michela Frascoli

Michela Frascoli

Auto-generated profile, based on publicly available information

Michela Frascoli

University of Massachusetts Chan Medical School, Worcester, Massachusetts, United States

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 April 2018 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
MFMichela Frascoli
Michela Frascoli
LCLacy Coniglio
Lacy Coniglio
Russell Gardner WittRussell Gardner Witt
Russell Gardner Witt
CJCerine Jeanty
Cerine Jeanty
SFShannon Fleck-Derderian
Shannon Fleck-Derderian
TMTippi C. MacKenzie
Tippi C. MacKenzie
Human fetal T cell activation against maternal antigens could promote uterine contractions in preterm labor.

4 October 2018 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
NMNidhi Malhotra
Nidhi Malhotra
YQYilin Qi
Yilin Qi
NSNicholas A. Spidale
Nicholas A. Spidale
MFMichela Frascoli
Michela Frascoli
BMBing Miu
Bing Miu
JKJoonsoo Kang
Joonsoo Kang
Natural killer T (NKT) cells expressing the invariant T cell receptor (iTCR) serve an essential function in clearance of certain pathogens and have been implicated in autoimmune and allergic diseases. Complex effector programs of these iNKT cells are wired in the thymus, and upon thymic egress, they can respond within hours of antigenic challenges, classifying iNKT cells as innate-like. It has been assumed that the successful rearrangement of the invariant iTCRα chain is the central event in the divergence of immature thymocytes to the NKT cell lineage, but molecular properties that render the iTCR signaling distinct to permit the T cell lineage diversification remain obscure. Here we show that the High Mobility Group (HMG) transcription factor (TF) SOX4 controls the production of iNKT cells by inducing MicroRNA-181 (Mir181) to enhance TCR signaling and Ca2+ fluxes in precursors. These results suggest the existence of tailored, permissive gene circuits in iNKT precursors for innate-like T cell development.

1 June 2019 in Current Opinion in Immunology
Verified
Journal Article
Closed access
NSNicholas A Spidale
Nicholas A Spidale
MFMichela Frascoli
Michela Frascoli
JKJoonsoo Kang
Joonsoo Kang

15 August 2022 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
MFMichela Frascoli
Michela Frascoli
ARAndrea Reboldi
Andrea Reboldi
JKJoonsoo Kang
Joonsoo Kang
Obesity is considered the primary environmental factor associated with morbidity and severity of wide-ranging inflammatory disorders. The molecular mechanism linking high-fat or cholesterol diet to imbalances in immune responses, beyond the increased production of generic inflammatory factors, is just beginning to emerge. Diet cholesterol by-products are now known to regulate function and migration of diverse immune cell subsets in tissues. The hydroxylated metabolites of cholesterol oxysterols as central regulators of immune cell positioning in lymphoid and mucocutaneous tissues is the focus of this review. Dedicated immunocyte cell surface receptors sense spatially distributed oxysterol tissue depots to tune cell metabolism and function, to achieve the “right place at the right time” axiom of efficient tissue immunity.

15 April 2026 in Blood Advances
Verified
Journal Article
Open access
TMTippi C. MacKenzie
Tippi C. MacKenzie
BLBillie R Lianoglou
Billie R Lianoglou
JGJuan Gonzalez
Juan Gonzalez
CDChristopher C Dvorak
Christopher C Dvorak
SKSandhya Kharbanda
Sandhya Kharbanda
EVElliott P. Vichinsky
Elliott P. Vichinsky
In utero hematopoietic cell transplantation (IUHCT) has the potential to treat patients who have hemoglobinopathies by harnessing the unique period of fetal tolerance to maternal cells, thereby enabling semi-allogeneic transplantation without conditioning or immunosuppression. We conducted a phase 1 clinical trial of IUHCT in fetuses with Alpha Thalassemia Major (ATM), a diagnosis that requires serial in utero transfusions (IUT) for survival. We also analyzed outcomes in fetuses with ATM treated with IUT alone in the same time period. Six fetuses underwent transplantation with maternal CD34+ cells (1.33 x 108 ± 2.67x107 cells/kg +1% T cells) at 23.1 ± 1.1 weeks' gestation. All received serial IUT and were delivered at or near term. Perinatal outcomes were broadly similar to those undergoing IUT alone. Two mothers received prophylactic antibiotics because of late positive cultures of harvested cells (without fetal adverse events). Low-level maternal microchimerism was detected in all recipients; T-cell hyporeactivity to maternal antigens was detected in 2/6 offspring but persisted in only one child. Cord blood from ATM-affected pregnancies demonstrated marked expansion of host hematopoietic stem and progenitor cells compared with healthy controls, suggesting a competitive disadvantage for donor cells in this disease context. Neurodevelopmental assessments were largely reassuring, with high quality of life scores. Overall, this protocol was safe and feasible but demonstrates the limitations of IUHCT for ATM without concurrent bone marrow conditioning. The favorable perinatal and neurologic outcomes in most offspring underscore the benefits of prenatal transfusions and the unmet medical need for developing definitive therapies for ATM. NCT02986698

17 September 2025 in Journal of Experimental Medicine
Verified
Journal Article
Closed access
MFMichela Frascoli
Michela Frascoli
DNDequina Angelina Nicholas
Dequina Angelina Nicholas
AWAda Weinstock
Ada Weinstock
CHChia-Lin Hsu
Chia-Lin Hsu
ADAnushka D. Dongre
Anushka D. Dongre
AMAlexandra McCubbrey
Alexandra McCubbrey
This year at JEM, we are highlighting women in science by sharing their stories and amplifying their voices. In this Viewpoint, we hear from a cross section of women, across multiple research fields, discussing their science and the process of setting up a lab as an independent researcher.